Resources
New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic OM1 partners with AHRQ, ABFM, APA and others to implement BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]
Published in DIA’s Therapeutic Innovation & Regulatory Science journal Authors: Richard E. Gliklich and Michelle B. Leavy Abstract: The use of real-world data and real-world evidence to inform health care decisions is increasing. Yet, the variable quality of these data and the lack of widely-accepted criteria by which to assess quality create uncertainty about how[…]
Research-Grade, Analytic-Ready Rheumatology Data at Your Fingertips through the IHD Platform What would you do with rapid access to analytics and insights from hundreds of thousands of rheumatology patients? Bringing together the largest linked, longitudinal rheumatology condition registries with the industry-leading Instant Health Data (IHD) platform, OM1 and BHE join forces to deliver a powerful[…]
BOSTON, April 30, 2019 — OM1, a leading health outcomes, data and technology company today announced that its rheumatology registries, which track hundreds of thousands of patients longitudinally throughout the United States, are now available for direct licensing as well as studies and advanced analytics. The registries include: Rheumatoid Arthritis Systemic Lupus Erythematosus Sjögrens Giant[…]
Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence Richard E. Gliklich MD, Michelle B. Leavy, MPH Sage Journals, First Published March 27, 2019 The use of real-world data and real-world evidence to inform health care decisions is increasing. Yet, the variable quality of these data and[…]
